anti-arrhythmic

2 marketed 1 in Phase 3

This page covers all anti-arrhythmic drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting Potassium channels.

Targets

Potassium channels

Marketed (2)

Phase 3 pipeline (1)